PEG-wLPrA2

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePEG-wLPrA2
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionLeptin receptor antagonists
TargetsLeptin receptor
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJyant Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJyant Technologies
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A